Unique ID issued by UMIN | UMIN000049296 |
---|---|
Receipt number | R000056146 |
Scientific Title | Analysis of multidisciplinary treatment using chemotherapy, carbon ion therapy, and surgery for stage II and III esophageal cancer |
Date of disclosure of the study information | 2022/11/01 |
Last modified on | 2023/11/10 08:23:52 |
Analysis of multidisciplinary treatment using chemotherapy, carbon ion therapy, and surgery for stage II and III esophageal cancer
Analysis of multidisciplinary treatment using chemotherapy, carbon ion therapy, and surgery for stage II and III esophageal cancer
Analysis of multidisciplinary treatment using chemotherapy, carbon ion therapy, and surgery for stage II and III esophageal cancer
Analysis of multidisciplinary treatment using chemotherapy, carbon ion therapy, and surgery for stage II and III esophageal cancer
Japan |
Stage II and III esophageal cancer
Gastroenterology | Gastrointestinal surgery | Radiology |
Malignancy
NO
To investigate the usefulness and safety of multidisciplinary treatment of chemotherapy, carbon ion therapy, and surgery for stage II and III esophageal cancer.
Safety,Efficacy
Adverse reactions in normal tissues
Observational
20 | years-old | <= |
75 | years-old | >= |
Male and Female
(1) Histologically confirmed thoracic esophageal squamous cell carcinoma.
(2) The clinical stage is II or III.
(3) Lesions for which therapeutic effects can be evaluated by endoscopy.
(4) Age is between 20 and 75 years old. Gender does not matter.
(5) PS (EROG) is 0 or 1.
(6) Radical treatment for esophageal cancer is possible.
(7) No history of treatment for esophageal cancer.
(8) The functions of major organs are maintained.
(9) Written informed consent has been obtained from the patient.
(1) Patients with a history of radiotherapy at the irradiation site.
(2) Active double cancer in other organs.
(3) Active interstitial pneumonia.
(4) Active and intractable infection in the planned irradiation area.
(5) HBs antigen, HCV antibody. HIV antibody and HTLV antibody positive.
(6) Cases judged inappropriate by the principal investigator
27
1st name | Tetsuro |
Middle name | |
Last name | Isozaki |
National Institutes for Quantum Sciences and Technology QST Hospital
Department of radiology
263-8555
4-9-1, anagawa, inage-ku,chiba. japan
043-206-3306
isozaki.tetsuro@qst.go.jp
1st name | Tetsuro |
Middle name | |
Last name | Isozaki |
National Institutes for Quantum Sciences and Technology QST Hospital
Department of radiology
263-8555
4-9-1, anagawa, inage-ku,chiba. japan
043-206-3306
isozaki.tetsuro@qst.go.jp
National Institutes for Quantum Sciences and Technology QST Hospital
National Institutes for Quantum Sciences and Technology QST Hospital
Other
Department of frontier surgery Graduate school of medicine, Chiba University
National Institutes for Quantum Sciences and Technology QST Hospital
4-9-1, anagawa, inage-ku,chiba. japan
043-206-3306
isozaki.tetsuro@qst.go.jp
NO
2022 | Year | 11 | Month | 01 | Day |
Unpublished
Completed
2022 | Year | 11 | Month | 01 | Day |
2022 | Year | 10 | Month | 13 | Day |
2022 | Year | 11 | Month | 01 | Day |
2023 | Year | 11 | Month | 01 | Day |
Data will be extracted from electronic medical records and other medical information processed in such a way that specific individuals cannot be identified unless the data is cross-checked with other information. Data from both Chiba University Hospital and QST Hospital will be shared for analysis.
2022 | Year | 10 | Month | 24 | Day |
2023 | Year | 11 | Month | 10 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000056146